These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34837441)

  • 41. Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.
    Silva-Rojas R; Nattarayan V; Jaque-Fernandez F; Gomez-Oca R; Menuet A; Reiss D; Goret M; Messaddeq N; Lionello VM; Kretz C; Cowling BS; Jacquemond V; Laporte J
    Mol Ther; 2022 Feb; 30(2):868-880. PubMed ID: 34371181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A rare case of centronuclear myopathy with
    Aghbolaghi AG; Lechpammer M
    Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations in dynamin 2 cause dominant centronuclear myopathy.
    Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
    Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Centronuclear myopathies: a widening concept.
    Romero NB
    Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
    Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
    Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical, Electrophysiology, and Pathology Features of Dynamin Centronuclear Myopathy: A Case Report and Review of Literature.
    Verma S; Balasubramanian SB
    J Clin Neuromuscul Dis; 2016 Dec; 18(2):84-88. PubMed ID: 27861221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy.
    Abath Neto O; Martins Cde A; Carvalho M; Chadi G; Seitz KW; Oliveira AS; Reed UC; Laporte J; Zanoteli E
    Genet Mol Biol; 2015 May; 38(2):147-51. PubMed ID: 26273216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease.
    Zhao M; Maani N; Dowling JJ
    Neurotherapeutics; 2018 Oct; 15(4):966-975. PubMed ID: 30426359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model.
    Li Q; Lin J; Widrick JJ; Luo S; Li G; Zhang Y; Laporte J; Perrella MA; Liu X; Agrawal PB
    JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35763354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel dynamin-2 gene mutation associated with a late-onset centronuclear myopathy with necklace fibres.
    Casar-Borota O; Jacobsson J; Libelius R; Oldfors CH; Malfatti E; Romero NB; Oldfors A
    Neuromuscul Disord; 2015 Apr; 25(4):345-8. PubMed ID: 25633151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases.
    Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M
    Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy.
    Espinosa KG; Geissah S; Groom L; Volpatti J; Scott IC; Dirksen RT; Zhao M; Dowling JJ
    Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35293586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Respiratory features of centronuclear myopathy in the Netherlands.
    Bouma S; Cobben N; Bouman K; Gaytant M; van de Biggelaar R; van Doorn J; Reumers SFI; Voet NB; Doorduin J; Erasmus CE; Kamsteeg EJ; Jungbluth H; Wijkstra P; Voermans NC
    Neuromuscul Disord; 2023 Jul; 33(7):580-588. PubMed ID: 37364426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation.
    Romero NB; Bevilacqua JA; Oldfors A; Fardeau M
    Neuromuscul Disord; 2011 Feb; 21(2):148; author reply 148-9. PubMed ID: 21247764
    [No Abstract]   [Full Text] [Related]  

  • 55. Impaired excitation-contraction coupling in muscle fibres from the dynamin2
    Kutchukian C; Szentesi P; Allard B; Trochet D; Beuvin M; Berthier C; Tourneur Y; Guicheney P; Csernoch L; Bitoun M; Jacquemond V
    J Physiol; 2017 Dec; 595(24):7369-7382. PubMed ID: 29071728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy.
    de Carvalho Neves J; Moschovaki-Filippidou F; Böhm J; Laporte J
    Mol Ther Nucleic Acids; 2023 Sep; 33():321-334. PubMed ID: 37547294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BIN1 modulation in vivo rescues dynamin-related myopathy.
    Lionello VM; Kretz C; Edelweiss E; Crucifix C; Gómez-Oca R; Messaddeq N; Buono S; Koebel P; Massana Muñoz X; Diedhiou N; Cowling BS; Bitoun M; Laporte J
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy.
    Gómez-Oca R; Edelweiss E; Djeddi S; Gerbier M; Massana-Muñoz X; Oulad-Abdelghani M; Crucifix C; Spiegelhalter C; Messaddeq N; Poussin-Courmontagne P; Koebel P; Cowling BS; Laporte J
    Nat Commun; 2022 Nov; 13(1):6849. PubMed ID: 36369230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamin 2 the rescue for centronuclear myopathy.
    Demonbreun AR; McNally EM
    J Clin Invest; 2014 Mar; 124(3):976-8. PubMed ID: 24569368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.
    Koutsopoulos OS; Koch C; Tosch V; Böhm J; North KN; Laporte J
    PLoS One; 2011; 6(11):e27498. PubMed ID: 22096584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.